AUSTRALIAN HEALTH-TECH MISSION TO ASIA
Helping leading-edge health tech companies access capital and scale in Asia
HONG KONG 12-17 May 2024
FREQUENTLY ASK QUESTIONS
The Mission aims to help leading-edge health-tech companies from Australia access capital and scale their businesses in Asia.
The Mission will take place in Hong Kong from 12-17 May 2024.
Delegates can provide a one-page teaser document outlining their proposition and offer to the local connections and project manager in Hong Kong, who will pre-qualify interest and get
feedback from potential investors and interested parties
We will propose a conveniently located hotel at an affordable price in Hong Kong for all
delegates, but we acknowledge that some delegates will have their own preference and will want to make their own arrangements.
All Mission packages include all activities detailed in the Mission Itinerary, including welcome and farewell dinner.
The Mission is limited to 30 places only.
The Mission leader is David Thomas, who has over two decades of experience in identifying,
building, and facilitating business and investment relationships between developed and emerging countries, particularly in China.
The key benefits include access to capital and funding, expanding market opportunities in Asia, and establishing a local presence in Asia, which can increase revenue, profits, and growth
opportunities for health-tech businesses.
We are actively reaching out to professional investors, including high-net- worth individuals,
family offices, venture capital firms, and institutions, from various channels- Our aim is to provide all delegates with the chance to connect and interact with committed pre-screened investors who have a genuine interest in the healthcare industry. In fact, many of these investors have already received a teaser document beforehand.
The facilitated pitch sessions are an opportunity for delegates to showcase their health-tech
venture to potential investors and collaborators. The sessions are organised with professional
translators and personalised matchmaking is provided to connect delegates with potential
investors, collaborators, and partners.
Yes, additional team members or guests can be added at an extra cost. However, the Mission is limited to 30 places only, so availability may be limited
The Mission is suitable for leading-edge health-tech companies from Australia that have a
potential for growth in Asia, including digital health, medical devices, precision medicine, and
regenerative medicine. Companies should have a well-prepared value proposition and offer, and be ready to engage with potential investors and partners.
Please refer to the Booking Form which sets out all the T&Cs for the mission and may answer
other questions not covered in the above.